Related and Nonrelated Parties [Axis]
Nonrelated Party [Member]
Related Party [Member]
Equity Components [Axis]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Treasury Stock, Common [Member]
Sale of Stock [Axis]
Private Placement [Member]
Subsequent Event Type [Axis]
Subsequent Event [Member]
Inventory [Axis]
Dental Finished Goods [Member]
Medical Finished Goods [Member]
Title and Position [Axis]
Officers Directors And Other Employees [Member]
Non-employees [Member]
Award Type [Axis]
Share-Based Payment Arrangement, Option [Member]
Grantee Status [Axis]
Share-Based Payment Arrangement, Nonemployee [Member]
Restricted Stock [Member]
Share-Based Payment Arrangement, Employee [Member]
Consolidation Items [Axis]
Segment Reporting, Reconciling Item, Corporate Nonsegment [Member]
Operating Segments [Member]
Segments [Axis]
Dental [Member]
Medical [Member]
Subsegments [Axis]
Grand Total [Member]
Dental Segment [Member]
Medical Segment [Member]
Concentration Risk Benchmark [Axis]
Revenue Benchmark [Member]
Concentration Risk Type [Axis]
Customer Concentration Risk [Member]
Customer [Axis]
E-Commerce [Member]
Distributor One [Member]
Accounts Receivable [Member]
Distributor Two [Member]
Distributor Three [Member]
Supplier Concentration Risk [Member]
Accounts Payable [Member]
Supplier One [Member]
Supplier Two [Member]
Supplier Three [Member]
Supplier Four [Member]
United Systems [Member]
Director of Clinical Affair [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Employment Agreement [Member]
Mr. Osser, Vice Chairman of Board [Member]
Consulting Agreement [Member]
University Pain Medicine Center (STEMMEE) [Member]
Jan Adriaan Arjan Haverhals [Member]
Arjan J Haverhals and Director [Member]
Mr. Haverhals, Consultant and Director [Member]
Mr. Neal Goldman, Ms. Benedetta Casamento, and Dr. Didier Demesmin [Member]
Mr Neal Goldman [Member]
Ms Benedetta Casamento [Member]
Dr Didier Demesmin [Member]
Innovest SPA [Member]
Purchase Commitment, Excluding Long-Term Commitment [Axis]
Purchase Commitment for Devices [Member]
Contracts for Funding of Future Epidural Instruments and Parts [Member]
Cover [Abstract]
Document Type
Amendment Flag
Amendment Description
Document Registration Statement
Document Annual Report
Document Quarterly Report
Document Transition Report
Document Shell Company Report
Document Shell Company Event Date
Document Period Start Date
Document Period End Date
Document Fiscal Period Focus
Document Fiscal Year Focus
Current Fiscal Year End Date
Entity File Number
Entity Registrant Name
Entity Central Index Key
Entity Primary SIC Number
Entity Tax Identification Number
Entity Incorporation, State or Country Code
Entity Address, Address Line One
Entity Address, Address Line Two
Entity Address, Address Line Three
Entity Address, City or Town
Entity Address, State or Province
Entity Address, Country
Entity Address, Postal Zip Code
Country Region
City Area Code
Local Phone Number
Extension
Written Communications
Soliciting Material
Pre-commencement Tender Offer
Pre-commencement Issuer Tender Offer
Title of 12(b) Security
No Trading Symbol Flag
Trading Symbol
Security Exchange Name
Title of 12(g) Security
Security Reporting Obligation
Annual Information Form
Audited Annual Financial Statements
Entity Well-known Seasoned Issuer
Entity Voluntary Filers
Entity Current Reporting Status
Entity Interactive Data Current
Entity Filer Category
Entity Small Business
Entity Emerging Growth Company
Elected Not To Use the Extended Transition Period
Document Accounting Standard
Other Reporting Standard Item Number
Entity Shell Company
Entity Public Float
Entity Bankruptcy Proceedings, Reporting Current
Entity Common Stock, Shares Outstanding
Documents Incorporated by Reference [Text Block]
Entity Listing, Par Value Per Share
Defined Benefit Plan [Table]
Defined Benefit Plan Disclosure [Line Items]
ASSETS
Current assets:
Cash and cash equivalents
Accounts receivable
Prepaid expenses and other current assets
Inventories
Advances on contracts
Total current assets
Furniture, fixtures and equipment, net
Intangibles, net
Right of use assets finance lease
Right of use assets operating lease
Deferred financing costs
Other assets
Total assets
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable
Accrued expenses
Current portion of finance lease liabilities
Current portion of operating lease liabilities
Total current liabilities
Non-current portion of finance lease liabilities
Non-current portion of operating lease liabilities
Convertible notes payable, related parties
Total liabilities
Commitments and contingencies
Stockholders’ equity
Common stock, par value $0.001; authorized 125,000,000 shares; 80,486,449 shares issued and 80,453,116 shares outstanding as of March 31, 2026; 80,486,449 shares issued and 80,453,116 shares outstanding as of December 31, 2025;
Additional paid in capital
Accumulated deficit
Treasury stock, at cost, 33,333 shares
Total Milestone Scientific Inc. stockholders’ equity
Total liabilities and stockholders’ equity
Allowance for credit loss
Common stock, par value
Common stock, shares authorized
Common stock, shares issued
Common stock, shares outstanding
Treasury stock, shares
Income Statement [Abstract]
Product sales, net
Cost of products sold
Gross profit
Selling, general and administrative expenses
Research and development expenses
Depreciation and amortization expense
Total operating expenses
Loss from operations
Interest (expense) income, net
Loss before provision for income taxes
Provision for income taxes
Net loss
Net loss per share applicable to common stockholders - basic
Net loss per share applicable to common stockholders - diluted
Weighted average shares outstanding and to be issued - basic
Weighted average shares outstanding and to be issued - diluted
Statement [Table]
Statement [Line Items]
Balance
Balance, shares
Stock based compensation
Common stock issued to board of directors for services
Net loss
Common stock to be issued to employees for bonuses
Common stock issued to board of directors for services, shares
Balance
Balance, shares
Statement of Cash Flows [Abstract]
Cash flows from operating activities:
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense
Amortization of intangibles
Stock based compensation
Employees paid in stock
Bad debt expense
Amortization of right-of-use asset
Changes in operating assets and liabilities:
Decrease (increase) in accounts receivable
Decrease (increase) in accounts receivable, related parties
Decrease (increase) in inventories
(Increase) decrease in advances on contracts
Increase in deferred financing costs
Increase in prepaid expenses and other current assets
Increase in accounts payable
(Decrease) increase in accounts payable, related party
Increase (decrease) in accrued expenses
Increase in accrued expenses, related party
Decrease operating right of use lease asset
Net cash provided by (used in) operating activities
Cash flows from investing activities:
Purchase of furniture, fixtures, and equipment
Net cash used in investing activities
Cash flows from financing activities:
Payments finance lease obligations
Net cash used in financing activities
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Pay vs Performance Disclosure [Table]
Executive Category [Axis]
Individual [Axis]
Adjustment to Compensation [Axis]
Measure [Axis]
Pay vs Performance Disclosure, Table
Company Selected Measure Name
Named Executive Officers, Footnote
Peer Group Issuers, Footnote
Changed Peer Group, Footnote
PEO Total Compensation Amount
PEO Actually Paid Compensation Amount
Adjustment To PEO Compensation, Footnote
Non-PEO NEO Average Total Compensation Amount
Non-PEO NEO Average Compensation Actually Paid Amount
Adjustment to Non-PEO NEO Compensation Footnote
Equity Valuation Assumption Difference, Footnote
Compensation Actually Paid vs. Total Shareholder Return
Compensation Actually Paid vs. Net Income
Compensation Actually Paid vs. Company Selected Measure
Total Shareholder Return Vs Peer Group
Compensation Actually Paid vs. Other Measure
Tabular List, Table
Total Shareholder Return Amount
Peer Group Total Shareholder Return Amount
Net Income (Loss)
Company Selected Measure Amount
Other Performance Measure, Amount
Adjustment to Compensation, Amount
PEO Name
Name
Non-GAAP Measure Description
Additional 402(v) Disclosure
Pension Benefits Adjustments, Footnote
Equity Awards Adjustments, Footnote
Erroneously Awarded Compensation Recovery [Table]
Restatement Determination Date [Axis]
Restatement Determination Date
Aggregate Erroneous Compensation Amount
Erroneous Compensation Analysis
Stock Price or TSR Estimation Method
Outstanding Aggregate Erroneous Compensation Amount
Aggregate Erroneous Compensation Not Yet Determined
Name
Forgone Recovery due to Expense of Enforcement, Amount
Forgone Recovery due to Violation of Home Country Law, Amount
Forgone Recovery due to Disqualification of Tax Benefits, Amount
Forgone Recovery, Explanation of Impracticability
Name
Compensation Amount
Restatement does not require Recovery
Awards Close in Time to MNPI Disclosures [Table]
Award Timing MNPI Disclosure
Award Timing Method
Award Timing Predetermined
Award Timing MNPI Considered
Award Timing, How MNPI Considered
MNPI Disclosure Timed for Compensation Value
Awards Close in Time to MNPI Disclosures, Table
Name
Underlying Securities
Exercise Price
Fair Value as of Grant Date
Underlying Security Market Price Change
Insider Trading Arrangements [Line Items]
Material Terms of Trading Arrangement
Name
Title
Rule 10b5-1 Arrangement Adopted
Non-Rule 10b5-1 Arrangement Adopted
Adoption Date
Rule 10b5-1 Arrangement Terminated
Non-Rule 10b5-1 Arrangement Terminated
Termination Date
Expiration Date
Arrangement Duration
Aggregate Available
No insider trading flag
Insider Trading Policies and Procedures [Line Items]
Insider Trading Policies and Procedures Adopted
Insider Trading Policies and Procedures Not Adopted
Organization, Consolidation and Presentation of Financial Statements [Abstract]
ORGANIZATION AND BUSINESS
GOING CONCERN AND LIQUIDITY
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Inventory Disclosure [Abstract]
INVENTORIES
Advances On Contracts
ADVANCES ON CONTRACTS
Equity [Abstract]
STOCKHOLDERS’ EQUITY
Share-Based Payment Arrangement [Abstract]
STOCK OPTION PLANS
Income Tax Disclosure [Abstract]
INCOME TAXES
Segment Reporting [Abstract]
SEGMENT AND GEOGRAPHIC DATA
Risks and Uncertainties [Abstract]
CONCENTRATIONS
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS
Subsequent Events [Abstract]
SUBSEQUENT EVENT
Principles of Consolidation
Basis of Presentation
Use of Estimates
Revenue Recognition
Cash and Cash Equivalents
Accounts Receivable
Inventories
Basic and Diluted Net Loss Per Common Share
Recent Accounting Pronouncements
SCHEDULE OF INVENTORIES
SCHEDULE OF SHARES TO BE ISSUED
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
SCHEDULE OF RESTRICTED STOCK
SCHEDULE OF RESTRICTED STOCK
SCHEDULE OF REPORTABLE AND OPERATING SEGMENTS
SCHEDULE OF COMPONENTS OF LEASE EXPENSE
Subsidiary or Equity Method Investee, Sale of Stock, Type [Table]
Subsidiary, Sale of Stock [Line Items]
Retained earnings
Operating losses
Cash
Working capital
Net cash flows used in operating activities
Sale of stock number of shares issued in transaction
Sale of stock price per share
Sale of stock consideration received per transaction
Cash
Convertible notes payable
Warrant exercise price
Proceeds from warrant exercise
Number of operating segments
Cash and Cash Equivalent
Cash, FDIC Insured Amount
Accounts receivable, net of allowance for credit losses
Weighted average number of common shares outstanding diluted
Anti-dilutive shares
Inventory, Current [Table]
Inventory [Line Items]
Inventory finished goods
Component parts and other materials
Total inventories
Inventory valuation reserves
StockholdersEquityTable [Table]
StockholdersEquityLineItems [Line Items]
Shares to be issued
Shares-to-be-issued, outstanding beginning balance
Granted in current period
Issued in current period
Shares-to be issued outstanding ending balance
Number of Options Outstanding, Beginning Balance
Weighted Averaged Exercise Price, Beginning Balance
Weighted Average Remaining Contractual Life (Years), Outstanding
Aggregate Intrinsic Options Value, Beginning Balance
Number of Options, Granted
Weighted Averaged Exercise Price, Granted
Number of Options, Exercised
Weighted Averaged Exercise Price, Exercised
Number of Options, Forfeited or expired
Weighted Averaged Exercise Price, Forfeited or expired
Number of Options Outstanding, Ending Balance
Weighted Averaged Exercise Price, Ending Balance
Aggregate Intrinsic Options Value, Ending Balance
Number of Options, Exercisable
Weighted Averaged Exercise Price, Exercisable
Weighted Average Remaining Contractual Life (Years), Exercisable
Aggregate Intrinsic Options Value, Exercisable
Number of Shares, Non-vested Beginning Balance
Weighted Average Grant-Date Fair Value per Award, Non-vested Beginning Balance
Number of Shares, Granted
Weighted Average Grant-Date Fair Value per Award, Granted
Number of Shares, Vested
Weighted Average Grant-Date Fair Value per Award, Vested
Number of Shares, Cancelled
Weighted Average Grant-Date Fair Value per Award, Cancelled
Number of Shares, Non-vested Ending Balance
Weighted Average Grant-Date Fair Value per Award, Non-vested Ending Balance
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period
General and administrative expenses
Unrecognized compensation expense
Weighted average period
Restricted stock awards granted
Fair market value per share
Vesting description
Percentage of valuation allowance
Segment Reporting [Table]
Segment Reporting [Line Items]
Gross Margin
Salaries & employee benefits
Stock Compensation
Royalty expense
Warehouse
Quality and Regulatory
Marketing
Rent & occupancy costs
Consultants and professional services fees
Insurance
Travel Expense
Research and development expense
Other segment items
Total operating expenses
Operating income (loss)
Total assets
Reportable segments
Concentration Risk [Table]
Concentration Risk [Line Items]
Concentration risk, percentage
Number of distributors
Number of suppliers
Related Party Transaction [Table]
Related Party Transaction [Line Items]
Related party transaction, amounts of transaction owed
Amounts owed
Accounts payable and accrued liabilities, current
Increase (decrease) in compensation
Employment agreement, base compensation
Compensation term
Consulting expense
Options granted to purchase common stock
Options vesting period
Options exercisable period
Shares issued and owned
Shares to be issued at employment termination
Related party transaction, amounts of transaction
Consulting fee payable
Agreed to waive
[custom:SharesToBeIssuedAfterEmployeesResignation]
Promissory notes
Interest rate
Gross proceeds from sale of equity securities
Ownership percentage
Market price
Sale of Stock, Number of Shares Issued in Transaction
Sale of Stock, Price Per Share
Sale of Stock, Consideration Received Per Transaction
Convertible Notes Payable
Class of Warrant or Right, Number of Securities Called by Warrants or Rights
Interest rate
Related party transaction description of transaction
Cash paid for operating lease liabilities
Cash paid for finance lease liabilities
Finance leases (years)
Operating leases (years)
Weighted-average discount rate - operating leases
Weighted-average discount rate - finance leases
Purchase Commitment, Excluding Long-Term Purchase Commitment [Table]
Purchase Commitment, Excluding Long-Term Commitment [Line Items]
[custom:PurchaseCommitmentNumberOfUnits]
Purchase Commitment, Remaining Minimum Amount Committed
Advances on inventory purchases
Subsequent Event [Table]
Subsequent Event [Line Items]
Proceeds from issuance of private placement
Represents the Value of stock issued for employee bonuses during the period.
The amount of noncash share-based compensation bonuses paid in stock.
Expenses paid stock.
Increase decrease to advances to contract manufacturer.
Decrease increase prepaid expenses and other current assets.
The increase (decrease) during the reporting period of accrued liabilities to related parties.
Amount of increase (decrease) in operating lease right-of-use asset.
Operating loss.
Working capital
Reclassifications [Policy Text Block]
Dental Finished Goods [Member]
Medical Finished Goods [Member]
Disclosure of advances to contract manufacturer.
Tabular disclosure of shares authorized for issuance under the deferred compensation arrangement as of the balance sheet date.
Number of shares granted pursuant to the terms of a deferred compensation arrangement.
Officers Directors And Other Employees [Member]
Non-employees [Member]
Share based compensation arrangement by share based payment award options granted weighted average remaining contractual granted term.
Proceeds from sale of net operating loss amount.
Sale of net operating losses physical presence requirement years
Represents the amount of contingent liability that a company must pay if they violate the terms of the sale of net operating losses.
Percentage of valuation allowance.
Dental [Member]
Medical [Member]
Grand Total [Member]
Represents all costs associated with storing, handling, and moving goods within a warehouse.
The costs a business incurs to comply with laws and regulations, encompassing everything from hiring compliance officers to paying fines for non-compliance.
E-Commerce [Member]
Represents the number of distributors.
Distributor One [Member]
Distributor Two [Member]
Distributor Three [Member]
Number of suppliers.
Supplier One [Member]
Supplier Two [Member]
Supplier Three [Member]
Supplier Four [Member]
United Systems [Member]
Director of Clinical Affair [Member]
Represents the royalty percentage on net sales.
Mr. Osser, Interim Chief Executive Officer [Member]
Mr. Osser, Vice Chairman of Board [Member]
Employment Agreement [Member]
The amount of annual base compensation pursuant to the employment agreement.
Consulting Agreement [Member]
Number of shares to be issued at employment termination.
University Pain Medicine Center (STEMMEE) [Member]
Amount of annual fee under consulting agreement.
Mr. Haverhals, Consultant and Director [Member]
In reference to the cash outflow for consulting services.
Arjan J Haverhals and Director [Member]
Agreed to waive.
The number of shares to be issued after the employees resignation.
Mr. Neal Goldman, Ms. Benedetta Casamento, and Dr. Didier Demesmin [Member]
Debt instrument equity securities issuance gross proceeds benchmark.
The number of units commitment to purchase.
Purchase Commitment for Devices [Member]
Development of the Next Generation Instrument [Member]
Contracts for Funding of Future Epidural Instruments and Parts [Member]
No insider trading flag.
Related Party and Nonrelated Party [Member]
Payment of transaction related expenses and outstanding obligations.
Jan Adriaan Arjan Haverhals [Member]
Increase decrease in deferred financing costs.
Dental Segment [Member]
Medical Segment [Member]
Mr Neal Goldman [Member]
Ms Benedetta Casamento [Member]
Dr Didier Demesmin [Member]
Innovest SPA [Member]
Assets, Current
Liabilities, Current
Liabilities
Treasury Stock, Value
Equity, Attributable to Parent
Liabilities and Equity
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
Income Tax Expense (Benefit)
Shares, Outstanding
Share-Based Payment Arrangement, Noncash Expense
Increase (Decrease) in Accounts Receivable
Increase (Decrease) in Accounts Receivable, Related Parties
Increase (Decrease) in Inventories
IncreaseDecreaseToAdvancesToContractManufacturer
IncreaseDecreaseInDeferredFinancingCosts
DecreaseIncreasePrepaidExpensesAndOtherCurrentAssets
IncreaseDecreaseInAccruedLiabilitiesRelatedParties
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
Payments to Acquire Property, Plant, and Equipment
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
Finance Lease, Principal Payments
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation
Forgone Recovery, Individual Name
Outstanding Recovery, Individual Name
Awards Close in Time to MNPI Disclosures, Individual Name
Trading Arrangement, Individual Name
Inventory, Policy [Policy Text Block]
Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]
Deferred Compensation Arrangement with Individual, Shares Issued
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period
Debt Instrument, Interest Rate During Period